TOPICAL COMPOSITIONS FOR THE TREATMENT OF CUTANEOUS LEISHMANIASIS

The present invention relates to a composition comprising a combination of a (halogenoacetamido)benzoate, a flavonol derivative and a terpene derivative, and, as exemple, relates to a composition comprising the combination of ethyl 3-(2-chloroacetamido)benzoate, dihydroquercetin and bisabolol. Said...

Full description

Saved in:
Bibliographic Details
Main Authors LE PAPE, Patrice, FELLOUS, Esther, AUCLAIR, Christian, KALIL-FILHO, Jorge E
Format Patent
LanguageEnglish
French
German
Published 15.07.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a composition comprising a combination of a (halogenoacetamido)benzoate, a flavonol derivative and a terpene derivative, and, as exemple, relates to a composition comprising the combination of ethyl 3-(2-chloroacetamido)benzoate, dihydroquercetin and bisabolol. Said composition is for use in the treatment of leishmaniasis, especially cutaneous or mucosal leishmaniasis, the composition being applied topically for concomitantly treating both parasitic infection and skin inflammation of the infected area induced by leishmaniasis.
Bibliography:Application Number: EP20180759341